IL214487A0 - N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof - Google Patents
N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereofInfo
- Publication number
- IL214487A0 IL214487A0 IL214487A IL21448711A IL214487A0 IL 214487 A0 IL214487 A0 IL 214487A0 IL 214487 A IL214487 A IL 214487A IL 21448711 A IL21448711 A IL 21448711A IL 214487 A0 IL214487 A0 IL 214487A0
- Authority
- IL
- Israel
- Prior art keywords
- azabicyclo
- oct
- aryl
- methyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900579A FR2941954B1 (en) | 2009-02-10 | 2009-02-10 | N- (6-AZA-BICYCLO ° 3.2.1! OCT-1-YL) -ARYL-METHYL DERIVATIVES BENZAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| PCT/FR2010/050204 WO2010092287A1 (en) | 2009-02-10 | 2010-02-09 | N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL214487A0 true IL214487A0 (en) | 2011-09-27 |
Family
ID=40935769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL214487A IL214487A0 (en) | 2009-02-10 | 2011-08-07 | N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2396335A1 (en) |
| JP (1) | JP2012517412A (en) |
| KR (1) | KR20110118813A (en) |
| CN (1) | CN102388050A (en) |
| AR (1) | AR075380A1 (en) |
| AU (1) | AU2010212703A1 (en) |
| BR (1) | BRPI1008544A2 (en) |
| CA (1) | CA2751866A1 (en) |
| FR (1) | FR2941954B1 (en) |
| IL (1) | IL214487A0 (en) |
| MX (1) | MX2011008459A (en) |
| SG (1) | SG173607A1 (en) |
| TW (1) | TW201034667A (en) |
| UY (1) | UY32429A (en) |
| WO (1) | WO2010092287A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861070B1 (en) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | DERIVATIVES OF N- [PHENYL (PYRROLIDIN-2-YL) METHYL] BENZAMIDE AND N - [(AZEPAN-2-YL) PHENYLMETHYL] BENZAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2861076B1 (en) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | N-HETEROCYCLYMETHYLBENZAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| WO2005058317A1 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Glycine transporter-1 inhibirors |
| WO2007053400A2 (en) * | 2005-10-28 | 2007-05-10 | Merck & Co., Inc. | Piperidine glycine transporter inhibitors |
| JP2010511615A (en) * | 2006-11-30 | 2010-04-15 | セナークス、バイオファーマ、インコーポレーテッド | Dialkylaminoalkyl esters of pivagabine as drugs for central nervous system disorders |
| TW200911808A (en) * | 2007-07-23 | 2009-03-16 | Astrazeneca Ab | Novel compounds |
-
2009
- 2009-02-10 FR FR0900579A patent/FR2941954B1/en not_active Expired - Fee Related
-
2010
- 2010-02-09 BR BRPI1008544A patent/BRPI1008544A2/en not_active Application Discontinuation
- 2010-02-09 KR KR1020117021204A patent/KR20110118813A/en not_active Application Discontinuation
- 2010-02-09 AU AU2010212703A patent/AU2010212703A1/en not_active Abandoned
- 2010-02-09 AR ARP100100345A patent/AR075380A1/en unknown
- 2010-02-09 MX MX2011008459A patent/MX2011008459A/en not_active Application Discontinuation
- 2010-02-09 JP JP2011548759A patent/JP2012517412A/en not_active Withdrawn
- 2010-02-09 SG SG2011057213A patent/SG173607A1/en unknown
- 2010-02-09 EP EP10708304A patent/EP2396335A1/en not_active Withdrawn
- 2010-02-09 CN CN2010800156289A patent/CN102388050A/en active Pending
- 2010-02-09 TW TW099104006A patent/TW201034667A/en unknown
- 2010-02-09 WO PCT/FR2010/050204 patent/WO2010092287A1/en active Application Filing
- 2010-02-09 CA CA2751866A patent/CA2751866A1/en not_active Abandoned
- 2010-02-10 UY UY0001032429A patent/UY32429A/en not_active Application Discontinuation
-
2011
- 2011-08-07 IL IL214487A patent/IL214487A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010092287A1 (en) | 2010-08-19 |
| CA2751866A1 (en) | 2010-08-19 |
| SG173607A1 (en) | 2011-09-29 |
| CN102388050A (en) | 2012-03-21 |
| UY32429A (en) | 2010-09-30 |
| EP2396335A1 (en) | 2011-12-21 |
| FR2941954A1 (en) | 2010-08-13 |
| AU2010212703A1 (en) | 2011-09-01 |
| TW201034667A (en) | 2010-10-01 |
| AR075380A1 (en) | 2011-03-30 |
| FR2941954B1 (en) | 2011-04-08 |
| MX2011008459A (en) | 2011-12-16 |
| KR20110118813A (en) | 2011-11-01 |
| BRPI1008544A2 (en) | 2016-03-15 |
| JP2012517412A (en) | 2012-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201005201B (en) | Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| IL207078A0 (en) | Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| HK1159108A1 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
| IL196113A0 (en) | N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| IL217208A0 (en) | Novel conjugates, preparation thereof, and therapeutic use thereof | |
| IL207195A0 (en) | Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof | |
| IL204663A0 (en) | Nicotinamide derivatives, preparastion thereof and therapeutic use thereof | |
| IL219888A0 (en) | Pyridine-pyridinone derivatives, preparation and therapeutic use thereof | |
| PL2146991T3 (en) | Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| ZA201103516B (en) | Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof | |
| IL207629A0 (en) | Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof | |
| IL217300A0 (en) | Pyrazole derivatives' prepartion thereof, and therapeutic use thereof | |
| IL190519A0 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
| IL215103A0 (en) | N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME | |
| PT2480540T (en) | Methylthioninium chloride pentahydrate, preparation and pharmaceutical use thereof | |
| SI2106401T1 (en) | Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof | |
| HK1164861A1 (en) | Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof | |
| HK1164862A1 (en) | 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof | |
| IL202474A0 (en) | 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof | |
| IL191892A0 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| EP2189451A4 (en) | Benzamide derivatives, their preparation and uses in medicine thereof | |
| IL214487A0 (en) | N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof | |
| ZA201000582B (en) | 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives,preparation and therapeutic use thereof | |
| SI2421864T1 (en) | 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof | |
| IL214490A0 (en) | N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof |